BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 31477094)

  • 1. First-degree family history of breast cancer is associated with prostate cancer risk: a systematic review and meta-analysis.
    Ren ZJ; Cao DH; Zhang Q; Ren PW; Liu LR; Wei Q; Wei WR; Dong Q
    BMC Cancer; 2019 Sep; 19(1):871. PubMed ID: 31477094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-degree family history of prostate cancer is associated the risk of breast cancer and ovarian cancer.
    Zheng Q; Ying Q; Ren Z; Zhang Q; Lu D; Wang H; Wei W
    Medicine (Baltimore); 2021 Jan; 100(4):e23816. PubMed ID: 33530178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between family history of cancer and breast cancer defined by estrogen and progesterone receptor status.
    Tutera AM; Sellers TA; Potter JD; Drinkard CR; Wiesner GL; Folsom AR
    Genet Epidemiol; 1996; 13(2):207-21. PubMed ID: 8722747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative risk of prostate cancer for men with affected relatives: systematic review and meta-analysis.
    Bruner DW; Moore D; Parlanti A; Dorgan J; Engstrom P
    Int J Cancer; 2003 Dec; 107(5):797-803. PubMed ID: 14566830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining the Impact of Family History on Detection of High-grade Prostate Cancer in a Large Multi-institutional Cohort.
    Clements MB; Vertosick EA; Guerrios-Rivera L; De Hoedt AM; Hernandez J; Liss MA; Leach RJ; Freedland SJ; Haese A; Montorsi F; Boorjian SA; Poyet C; Ankerst DP; Vickers AJ
    Eur Urol; 2022 Aug; 82(2):163-169. PubMed ID: 34980493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial clustering of breast and prostate cancers and risk of postmenopausal breast cancer.
    Sellers TA; Potter JD; Rich SS; Drinkard CR; Bostick RM; Kushi LH; Zheng W; Folsom AR
    J Natl Cancer Inst; 1994 Dec; 86(24):1860-5. PubMed ID: 7990161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial risk of prostate cancer in Iceland.
    Eldon BJ; Jonsson E; Tomasson J; Tryggvadottir L; Tulinius H
    BJU Int; 2003 Dec; 92(9):915-9. PubMed ID: 14632846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Family History of Breast Cancer, Breast Density, and Breast Cancer Risk in a U.S. Breast Cancer Screening Population.
    Ahern TP; Sprague BL; Bissell MCS; Miglioretti DL; Buist DSM; Braithwaite D; Kerlikowske K
    Cancer Epidemiol Biomarkers Prev; 2017 Jun; 26(6):938-944. PubMed ID: 28096200
    [No Abstract]   [Full Text] [Related]  

  • 9. Aggregation of ovarian cancer with breast, ovarian, colorectal, and prostate cancer in first-degree relatives.
    Tung KH; Goodman MT; Wu AH; McDuffie K; Wilkens LR; Nomura AM; Kolonel LN
    Am J Epidemiol; 2004 Apr; 159(8):750-8. PubMed ID: 15051584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Family History of Breast or Prostate Cancer and Prostate Cancer Risk.
    Barber L; Gerke T; Markt SC; Peisch SF; Wilson KM; Ahearn T; Giovannucci E; Parmigiani G; Mucci LA
    Clin Cancer Res; 2018 Dec; 24(23):5910-5917. PubMed ID: 30082473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Family history and the risk of breast cancer: a systematic review and meta-analysis.
    Pharoah PD; Day NE; Duffy S; Easton DF; Ponder BA
    Int J Cancer; 1997 May; 71(5):800-9. PubMed ID: 9180149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Family history and the risk of prostate cancer.
    Kalish LA; McDougal WS; McKinlay JB
    Urology; 2000 Nov; 56(5):803-6. PubMed ID: 11068306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is magnetic resonance imaging-targeted biopsy a useful addition to systematic confirmatory biopsy in men on active surveillance for low-risk prostate cancer? A systematic review and meta-analysis.
    Schoots IG; Nieboer D; Giganti F; Moore CM; Bangma CH; Roobol MJ
    BJU Int; 2018 Dec; 122(6):946-958. PubMed ID: 29679430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporation of detailed family history from the Swedish Family Cancer Database into the PCPT risk calculator.
    Grill S; Fallah M; Leach RJ; Thompson IM; Freedland S; Hemminki K; Ankerst DP
    J Urol; 2015 Feb; 193(2):460-5. PubMed ID: 25242395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating Family History Links between Breast Cancer and Prostate Cancer Among PLCO Trial Participants.
    Abdel-Rahman O
    Clin Breast Cancer; 2020 Aug; 20(4):300-306. PubMed ID: 32327298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer risk prediction based on complete prostate cancer family history.
    Albright F; Stephenson RA; Agarwal N; Teerlink CC; Lowrance WT; Farnham JM; Albright LA
    Prostate; 2015 Mar; 75(4):390-8. PubMed ID: 25408531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-Based Relative Risks for Lung Cancer Based on Complete Family History of Lung Cancer.
    Cannon-Albright LA; Carr SR; Akerley W
    J Thorac Oncol; 2019 Jul; 14(7):1184-1191. PubMed ID: 31075544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An epidemiological reappraisal of the familial aggregation of prostate cancer: a meta-analysis.
    Kiciński M; Vangronsveld J; Nawrot TS
    PLoS One; 2011; 6(10):e27130. PubMed ID: 22073129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer.
    Grabrick DM; Hartmann LC; Cerhan JR; Vierkant RA; Therneau TM; Vachon CM; Olson JE; Couch FJ; Anderson KE; Pankratz VS; Sellers TA
    JAMA; 2000 Oct; 284(14):1791-8. PubMed ID: 11025831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Family history of breast cancer as a predictor for fatal prostate cancer.
    Rodríguez C; Calle EE; Tatham LM; Wingo PA; Miracle-McMahill HL; Thun MJ; Heath CW
    Epidemiology; 1998 Sep; 9(5):525-9. PubMed ID: 9730031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.